Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Modern hair restoration surgery has advanced greatly since 1959.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Finasteride can help regrow hair in male pattern baldness.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss linked to prostate enlargement; stress and family history important factors.

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Men with severe hair loss may have poorer sperm quality.

Men with early-onset baldness may have a higher risk of heart disease.

Family history affects hair loss severity and onset more in men than women.

Androgenetic alopecia is more common in males, can be influenced by lifestyle, and may be linked to other skin issues.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Early-onset hair loss is linked to Parkinson's disease and decreased fertility.

Lifestyle factors like frequent shampooing and mental labor are linked to androgenetic alopecia.

Genetic testing can help understand male pattern baldness.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Baldness may indicate higher heart disease risk in men.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Hesperidin helps protect against testicular damage caused by finasteride.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

5% minoxidil is safe and effective for treating male hair loss.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.